0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Targeted Sequencing and Resequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-5Q13659
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Targeted Sequencing and Resequencing Market Research Report 2023
BUY CHAPTERS

Targeted Sequencing and Resequencing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-5Q13659
Report
October 2024
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Targeted Sequencing and Resequencing - Market Size

The global market for Targeted Sequencing and Resequencing was estimated to be worth US$ 45 million in 2023 and is forecast to a readjusted size of US$ 57 million by 2030 with a CAGR of 3.6% during the forecast period 2024-2030

Targeted Sequencing and Resequencing - Market

Targeted Sequencing and Resequencing - Market

The market trend for targeted sequencing and resequencing is experiencing significant growth. This can be attributed to several factors:Advancements in sequencing technologies: The development of high-throughput sequencing technologies, such as next-generation sequencing (NGS), has revolutionized the field of genomics. These technologies enable cost-effective and rapid sequencing of DNA and RNA samples. Targeted sequencing and resequencing techniques, which focus on specific regions of the genome or specific genetic variants, have become increasingly popular due to their efficiency and affordability.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Targeted Sequencing and Resequencing, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Targeted Sequencing and Resequencing by region & country, by Type, and by Application.
The Targeted Sequencing and Resequencing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Sequencing and Resequencing.
Market Segmentation

Scope of Targeted Sequencing and Resequencing - Market Report

Report Metric Details
Report Name Targeted Sequencing and Resequencing - Market
Forecasted market size in 2030 US$ 57 million
CAGR 3.6%
Forecasted years 2024 - 2030
Segment by Type:
  • DNA-based Targeted Sequencing
  • RNA-based Targeted Sequencing
Segment by Application
  • Clinical Application
  • Plant and Animal Sciences
  • Drug Development
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Agilent Technologies, Illumina, F. Hoffmann-La Roche, Thermo Fisher Scientific, DNASTAR, PacBio, Bio-Rad Laboratories, Integrated DNA Technologies, Perkin Elmer, RainDance Technologies, PierianDx, BGI, Genomatix GmbH, Macrogen, GATC Biotech Ag, Oxford Nanopore Technologies, QIAGEN
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Targeted Sequencing and Resequencing manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Targeted Sequencing and Resequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Targeted Sequencing and Resequencing in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Targeted Sequencing and Resequencing - Market size in 2030?

Ans: The Targeted Sequencing and Resequencing - Market size in 2030 will be US$ 57 million.

Who are the main players in the Targeted Sequencing and Resequencing - Market report?

Ans: The main players in the Targeted Sequencing and Resequencing - Market are Agilent Technologies, Illumina, F. Hoffmann-La Roche, Thermo Fisher Scientific, DNASTAR, PacBio, Bio-Rad Laboratories, Integrated DNA Technologies, Perkin Elmer, RainDance Technologies, PierianDx, BGI, Genomatix GmbH, Macrogen, GATC Biotech Ag, Oxford Nanopore Technologies, QIAGEN

What are the Application segmentation covered in the Targeted Sequencing and Resequencing - Market report?

Ans: The Applications covered in the Targeted Sequencing and Resequencing - Market report are Clinical Application, Plant and Animal Sciences, Drug Development, Others

What are the Type segmentation covered in the Targeted Sequencing and Resequencing - Market report?

Ans: The Types covered in the Targeted Sequencing and Resequencing - Market report are DNA-based Targeted Sequencing, RNA-based Targeted Sequencing

1 Market Overview
1.1 Targeted Sequencing and Resequencing Product Introduction
1.2 Global Targeted Sequencing and Resequencing Market Size Forecast
1.3 Targeted Sequencing and Resequencing Market Trends & Drivers
1.3.1 Targeted Sequencing and Resequencing Industry Trends
1.3.2 Targeted Sequencing and Resequencing Market Drivers & Opportunity
1.3.3 Targeted Sequencing and Resequencing Market Challenges
1.3.4 Targeted Sequencing and Resequencing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Targeted Sequencing and Resequencing Players Revenue Ranking (2023)
2.2 Global Targeted Sequencing and Resequencing Revenue by Company (2019-2024)
2.3 Key Companies Targeted Sequencing and Resequencing Manufacturing Base Distribution and Headquarters
2.4 Key Companies Targeted Sequencing and Resequencing Product Offered
2.5 Key Companies Time to Begin Mass Production of Targeted Sequencing and Resequencing
2.6 Targeted Sequencing and Resequencing Market Competitive Analysis
2.6.1 Targeted Sequencing and Resequencing Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Targeted Sequencing and Resequencing Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Sequencing and Resequencing as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 DNA-based Targeted Sequencing
3.1.2 RNA-based Targeted Sequencing
3.2 Global Targeted Sequencing and Resequencing Sales Value by Type
3.2.1 Global Targeted Sequencing and Resequencing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Targeted Sequencing and Resequencing Sales Value, by Type (2019-2030)
3.2.3 Global Targeted Sequencing and Resequencing Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinical Application
4.1.2 Plant and Animal Sciences
4.1.3 Drug Development
4.1.4 Others
4.2 Global Targeted Sequencing and Resequencing Sales Value by Application
4.2.1 Global Targeted Sequencing and Resequencing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Targeted Sequencing and Resequencing Sales Value, by Application (2019-2030)
4.2.3 Global Targeted Sequencing and Resequencing Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Targeted Sequencing and Resequencing Sales Value by Region
5.1.1 Global Targeted Sequencing and Resequencing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Targeted Sequencing and Resequencing Sales Value by Region (2019-2024)
5.1.3 Global Targeted Sequencing and Resequencing Sales Value by Region (2025-2030)
5.1.4 Global Targeted Sequencing and Resequencing Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Targeted Sequencing and Resequencing Sales Value, 2019-2030
5.2.2 North America Targeted Sequencing and Resequencing Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Targeted Sequencing and Resequencing Sales Value, 2019-2030
5.3.2 Europe Targeted Sequencing and Resequencing Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Targeted Sequencing and Resequencing Sales Value, 2019-2030
5.4.2 Asia Pacific Targeted Sequencing and Resequencing Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Targeted Sequencing and Resequencing Sales Value, 2019-2030
5.5.2 South America Targeted Sequencing and Resequencing Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Targeted Sequencing and Resequencing Sales Value, 2019-2030
5.6.2 Middle East & Africa Targeted Sequencing and Resequencing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Targeted Sequencing and Resequencing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Targeted Sequencing and Resequencing Sales Value
6.3 United States
6.3.1 United States Targeted Sequencing and Resequencing Sales Value, 2019-2030
6.3.2 United States Targeted Sequencing and Resequencing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Targeted Sequencing and Resequencing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Targeted Sequencing and Resequencing Sales Value, 2019-2030
6.4.2 Europe Targeted Sequencing and Resequencing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Targeted Sequencing and Resequencing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Targeted Sequencing and Resequencing Sales Value, 2019-2030
6.5.2 China Targeted Sequencing and Resequencing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Targeted Sequencing and Resequencing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Targeted Sequencing and Resequencing Sales Value, 2019-2030
6.6.2 Japan Targeted Sequencing and Resequencing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Targeted Sequencing and Resequencing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Targeted Sequencing and Resequencing Sales Value, 2019-2030
6.7.2 South Korea Targeted Sequencing and Resequencing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Targeted Sequencing and Resequencing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Targeted Sequencing and Resequencing Sales Value, 2019-2030
6.8.2 Southeast Asia Targeted Sequencing and Resequencing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Targeted Sequencing and Resequencing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Targeted Sequencing and Resequencing Sales Value, 2019-2030
6.9.2 India Targeted Sequencing and Resequencing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Targeted Sequencing and Resequencing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Profile
7.1.2 Agilent Technologies Main Business
7.1.3 Agilent Technologies Targeted Sequencing and Resequencing Products, Services and Solutions
7.1.4 Agilent Technologies Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.1.5 Agilent Technologies Recent Developments
7.2 Illumina
7.2.1 Illumina Profile
7.2.2 Illumina Main Business
7.2.3 Illumina Targeted Sequencing and Resequencing Products, Services and Solutions
7.2.4 Illumina Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.2.5 Illumina Recent Developments
7.3 F. Hoffmann-La Roche
7.3.1 F. Hoffmann-La Roche Profile
7.3.2 F. Hoffmann-La Roche Main Business
7.3.3 F. Hoffmann-La Roche Targeted Sequencing and Resequencing Products, Services and Solutions
7.3.4 F. Hoffmann-La Roche Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.3.5 Thermo Fisher Scientific Recent Developments
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Profile
7.4.2 Thermo Fisher Scientific Main Business
7.4.3 Thermo Fisher Scientific Targeted Sequencing and Resequencing Products, Services and Solutions
7.4.4 Thermo Fisher Scientific Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.4.5 Thermo Fisher Scientific Recent Developments
7.5 DNASTAR
7.5.1 DNASTAR Profile
7.5.2 DNASTAR Main Business
7.5.3 DNASTAR Targeted Sequencing and Resequencing Products, Services and Solutions
7.5.4 DNASTAR Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.5.5 DNASTAR Recent Developments
7.6 PacBio
7.6.1 PacBio Profile
7.6.2 PacBio Main Business
7.6.3 PacBio Targeted Sequencing and Resequencing Products, Services and Solutions
7.6.4 PacBio Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.6.5 PacBio Recent Developments
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Profile
7.7.2 Bio-Rad Laboratories Main Business
7.7.3 Bio-Rad Laboratories Targeted Sequencing and Resequencing Products, Services and Solutions
7.7.4 Bio-Rad Laboratories Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.7.5 Bio-Rad Laboratories Recent Developments
7.8 Integrated DNA Technologies
7.8.1 Integrated DNA Technologies Profile
7.8.2 Integrated DNA Technologies Main Business
7.8.3 Integrated DNA Technologies Targeted Sequencing and Resequencing Products, Services and Solutions
7.8.4 Integrated DNA Technologies Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.8.5 Integrated DNA Technologies Recent Developments
7.9 Perkin Elmer
7.9.1 Perkin Elmer Profile
7.9.2 Perkin Elmer Main Business
7.9.3 Perkin Elmer Targeted Sequencing and Resequencing Products, Services and Solutions
7.9.4 Perkin Elmer Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.9.5 Perkin Elmer Recent Developments
7.10 RainDance Technologies
7.10.1 RainDance Technologies Profile
7.10.2 RainDance Technologies Main Business
7.10.3 RainDance Technologies Targeted Sequencing and Resequencing Products, Services and Solutions
7.10.4 RainDance Technologies Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.10.5 RainDance Technologies Recent Developments
7.11 PierianDx
7.11.1 PierianDx Profile
7.11.2 PierianDx Main Business
7.11.3 PierianDx Targeted Sequencing and Resequencing Products, Services and Solutions
7.11.4 PierianDx Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.11.5 PierianDx Recent Developments
7.12 BGI
7.12.1 BGI Profile
7.12.2 BGI Main Business
7.12.3 BGI Targeted Sequencing and Resequencing Products, Services and Solutions
7.12.4 BGI Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.12.5 BGI Recent Developments
7.13 Genomatix GmbH
7.13.1 Genomatix GmbH Profile
7.13.2 Genomatix GmbH Main Business
7.13.3 Genomatix GmbH Targeted Sequencing and Resequencing Products, Services and Solutions
7.13.4 Genomatix GmbH Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.13.5 Genomatix GmbH Recent Developments
7.14 Macrogen
7.14.1 Macrogen Profile
7.14.2 Macrogen Main Business
7.14.3 Macrogen Targeted Sequencing and Resequencing Products, Services and Solutions
7.14.4 Macrogen Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.14.5 Macrogen Recent Developments
7.15 GATC Biotech Ag
7.15.1 GATC Biotech Ag Profile
7.15.2 GATC Biotech Ag Main Business
7.15.3 GATC Biotech Ag Targeted Sequencing and Resequencing Products, Services and Solutions
7.15.4 GATC Biotech Ag Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.15.5 GATC Biotech Ag Recent Developments
7.16 Oxford Nanopore Technologies
7.16.1 Oxford Nanopore Technologies Profile
7.16.2 Oxford Nanopore Technologies Main Business
7.16.3 Oxford Nanopore Technologies Targeted Sequencing and Resequencing Products, Services and Solutions
7.16.4 Oxford Nanopore Technologies Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.16.5 Oxford Nanopore Technologies Recent Developments
7.17 QIAGEN
7.17.1 QIAGEN Profile
7.17.2 QIAGEN Main Business
7.17.3 QIAGEN Targeted Sequencing and Resequencing Products, Services and Solutions
7.17.4 QIAGEN Targeted Sequencing and Resequencing Revenue (US$ Million) & (2019-2024)
7.17.5 QIAGEN Recent Developments
8 Industry Chain Analysis
8.1 Targeted Sequencing and Resequencing Industrial Chain
8.2 Targeted Sequencing and Resequencing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Targeted Sequencing and Resequencing Sales Model
8.5.2 Sales Channel
8.5.3 Targeted Sequencing and Resequencing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Targeted Sequencing and Resequencing Market Trends
    Table 2. Targeted Sequencing and Resequencing Market Drivers & Opportunity
    Table 3. Targeted Sequencing and Resequencing Market Challenges
    Table 4. Targeted Sequencing and Resequencing Market Restraints
    Table 5. Global Targeted Sequencing and Resequencing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Targeted Sequencing and Resequencing Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Targeted Sequencing and Resequencing Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Targeted Sequencing and Resequencing Product Type
    Table 9. Key Companies Time to Begin Mass Production of Targeted Sequencing and Resequencing
    Table 10. Global Targeted Sequencing and Resequencing Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Sequencing and Resequencing as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Targeted Sequencing and Resequencing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Targeted Sequencing and Resequencing Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Targeted Sequencing and Resequencing Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Targeted Sequencing and Resequencing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Targeted Sequencing and Resequencing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Targeted Sequencing and Resequencing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Targeted Sequencing and Resequencing Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Targeted Sequencing and Resequencing Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Targeted Sequencing and Resequencing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Targeted Sequencing and Resequencing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Targeted Sequencing and Resequencing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Targeted Sequencing and Resequencing Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Targeted Sequencing and Resequencing Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Targeted Sequencing and Resequencing Sales Value by Region (2019-2024) & (%)
    Table 27. Global Targeted Sequencing and Resequencing Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Targeted Sequencing and Resequencing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Targeted Sequencing and Resequencing Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Targeted Sequencing and Resequencing Sales Value, (2025-2030) & (US$ Million)
    Table 31. Agilent Technologies Basic Information List
    Table 32. Agilent Technologies Description and Business Overview
    Table 33. Agilent Technologies Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of Agilent Technologies (2019-2024)
    Table 35. Agilent Technologies Recent Developments
    Table 36. Illumina Basic Information List
    Table 37. Illumina Description and Business Overview
    Table 38. Illumina Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of Illumina (2019-2024)
    Table 40. Illumina Recent Developments
    Table 41. F. Hoffmann-La Roche Basic Information List
    Table 42. F. Hoffmann-La Roche Description and Business Overview
    Table 43. F. Hoffmann-La Roche Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of F. Hoffmann-La Roche (2019-2024)
    Table 45. F. Hoffmann-La Roche Recent Developments
    Table 46. Thermo Fisher Scientific Basic Information List
    Table 47. Thermo Fisher Scientific Description and Business Overview
    Table 48. Thermo Fisher Scientific Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of Thermo Fisher Scientific (2019-2024)
    Table 50. Thermo Fisher Scientific Recent Developments
    Table 51. DNASTAR Basic Information List
    Table 52. DNASTAR Description and Business Overview
    Table 53. DNASTAR Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of DNASTAR (2019-2024)
    Table 55. DNASTAR Recent Developments
    Table 56. PacBio Basic Information List
    Table 57. PacBio Description and Business Overview
    Table 58. PacBio Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of PacBio (2019-2024)
    Table 60. PacBio Recent Developments
    Table 61. Bio-Rad Laboratories Basic Information List
    Table 62. Bio-Rad Laboratories Description and Business Overview
    Table 63. Bio-Rad Laboratories Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of Bio-Rad Laboratories (2019-2024)
    Table 65. Bio-Rad Laboratories Recent Developments
    Table 66. Integrated DNA Technologies Basic Information List
    Table 67. Integrated DNA Technologies Description and Business Overview
    Table 68. Integrated DNA Technologies Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of Integrated DNA Technologies (2019-2024)
    Table 70. Integrated DNA Technologies Recent Developments
    Table 71. Perkin Elmer Basic Information List
    Table 72. Perkin Elmer Description and Business Overview
    Table 73. Perkin Elmer Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of Perkin Elmer (2019-2024)
    Table 75. Perkin Elmer Recent Developments
    Table 76. RainDance Technologies Basic Information List
    Table 77. RainDance Technologies Description and Business Overview
    Table 78. RainDance Technologies Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of RainDance Technologies (2019-2024)
    Table 80. RainDance Technologies Recent Developments
    Table 81. PierianDx Basic Information List
    Table 82. PierianDx Description and Business Overview
    Table 83. PierianDx Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of PierianDx (2019-2024)
    Table 85. PierianDx Recent Developments
    Table 86. BGI Basic Information List
    Table 87. BGI Description and Business Overview
    Table 88. BGI Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of BGI (2019-2024)
    Table 90. BGI Recent Developments
    Table 91. Genomatix GmbH Basic Information List
    Table 92. Genomatix GmbH Description and Business Overview
    Table 93. Genomatix GmbH Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of Genomatix GmbH (2019-2024)
    Table 95. Genomatix GmbH Recent Developments
    Table 96. Macrogen Basic Information List
    Table 97. Macrogen Description and Business Overview
    Table 98. Macrogen Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of Macrogen (2019-2024)
    Table 100. Macrogen Recent Developments
    Table 101. GATC Biotech Ag Basic Information List
    Table 102. GATC Biotech Ag Description and Business Overview
    Table 103. GATC Biotech Ag Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 104. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of GATC Biotech Ag (2019-2024)
    Table 105. GATC Biotech Ag Recent Developments
    Table 106. Oxford Nanopore Technologies Basic Information List
    Table 107. Oxford Nanopore Technologies Description and Business Overview
    Table 108. Oxford Nanopore Technologies Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 109. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of Oxford Nanopore Technologies (2019-2024)
    Table 110. Oxford Nanopore Technologies Recent Developments
    Table 111. QIAGEN Basic Information List
    Table 112. QIAGEN Description and Business Overview
    Table 113. QIAGEN Targeted Sequencing and Resequencing Products, Services and Solutions
    Table 114. Revenue (US$ Million) in Targeted Sequencing and Resequencing Business of QIAGEN (2019-2024)
    Table 115. QIAGEN Recent Developments
    Table 116. Key Raw Materials Lists
    Table 117. Raw Materials Key Suppliers Lists
    Table 118. Targeted Sequencing and Resequencing Downstream Customers
    Table 119. Targeted Sequencing and Resequencing Distributors List
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
    Table 123. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Targeted Sequencing and Resequencing Product Picture
    Figure 2. Global Targeted Sequencing and Resequencing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Targeted Sequencing and Resequencing Sales Value (2019-2030) & (US$ Million)
    Figure 4. Targeted Sequencing and Resequencing Report Years Considered
    Figure 5. Global Targeted Sequencing and Resequencing Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Targeted Sequencing and Resequencing Revenue in 2023
    Figure 7. Targeted Sequencing and Resequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. DNA-based Targeted Sequencing Picture
    Figure 9. RNA-based Targeted Sequencing Picture
    Figure 10. Global Targeted Sequencing and Resequencing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Targeted Sequencing and Resequencing Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Clinical Application
    Figure 13. Product Picture of Plant and Animal Sciences
    Figure 14. Product Picture of Drug Development
    Figure 15. Product Picture of Others
    Figure 16. Global Targeted Sequencing and Resequencing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Targeted Sequencing and Resequencing Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Targeted Sequencing and Resequencing Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Targeted Sequencing and Resequencing Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Targeted Sequencing and Resequencing Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Targeted Sequencing and Resequencing Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Targeted Sequencing and Resequencing Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Targeted Sequencing and Resequencing Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Targeted Sequencing and Resequencing Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Targeted Sequencing and Resequencing Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Targeted Sequencing and Resequencing Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Targeted Sequencing and Resequencing Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Targeted Sequencing and Resequencing Sales Value (%), (2019-2030)
    Figure 29. United States Targeted Sequencing and Resequencing Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Targeted Sequencing and Resequencing Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Targeted Sequencing and Resequencing Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Targeted Sequencing and Resequencing Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Targeted Sequencing and Resequencing Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Targeted Sequencing and Resequencing Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Targeted Sequencing and Resequencing Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Targeted Sequencing and Resequencing Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Targeted Sequencing and Resequencing Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Targeted Sequencing and Resequencing Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Targeted Sequencing and Resequencing Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Targeted Sequencing and Resequencing Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Targeted Sequencing and Resequencing Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Targeted Sequencing and Resequencing Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Targeted Sequencing and Resequencing Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Targeted Sequencing and Resequencing Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Targeted Sequencing and Resequencing Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Targeted Sequencing and Resequencing Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Targeted Sequencing and Resequencing Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Targeted Sequencing and Resequencing Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Targeted Sequencing and Resequencing Sales Value by Application (%), 2023 VS 2030
    Figure 50. Targeted Sequencing and Resequencing Industrial Chain
    Figure 51. Targeted Sequencing and Resequencing Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS